We first assessed the anti-SARS-CoV-2 RBD IgA, IgG, and IgM antibody concentrations in the serum, urine, and feces of this COVID-19 IgAN case and compared them with those of healthy controls. The gene discussed is CD79A; the disease is COVID-19.